Ceragenix Pharmaceuticals - Colorado business, 7/27
Colorado business, 7/27
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical
Chemical to block HIV infection identified
Onlypunjab.com - The chemical was developed by scientists at Brigham Young University, Utah, and is licensed to a company called Ceragenix Pharmaceuticals. Brigham Young University and Vanderbilt have jointly filed a patent on the compounds, the report said. US
Innovations & ideas, 7/2
Denver Post - A Denver-based biotechnology company is looking at ways to treat eczema in children without using steroids. Ceragenix Pharmaceuticals Inc. said last week that it will begin a study of its topical cream Epiceram to see if it works just as well on
Ceragenix Pharmaceuticals, Inc. CEO Featured in Exclusive Interview
KASA Fox 2 - NEW YORK, July 13 /PRNewswire-FirstCall/ -- On July 12, Steven Porter, CEO of Ceragenix Pharmaceuticals, Inc. updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview include an overview of the
0 Comments:
Post a Comment
<< Ceragenix Pharmaceuticals: Ceragenix Pharmaceuticals - Colorado business, 7/27 Home Page